Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 204, Issue 3, Pages 358-362Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jir265
Keywords
-
Categories
Funding
- Wellcome Trust [GR076210MA]
- Senior National Institute for Health Research (NIHR)
- Department of Health (National Health Service Chair of Pharmacogenetics)
- Medical Research Council (MRC Centre for Drug Safety Science)
- European Commission
Ask authors/readers for more resources
Up to 14% of Malawian adults die during the intensive phase of tuberculosis treatment. In a prospective cohort of 199 Malawian adults with microbiologically confirmed pulmonary tuberculosis, clinical and laboratory parameters were compared between those who died or deteriorated with those who had an uneventful recovery. Baseline tumor necrosis factor alpha responses to stimulation with heat-killed Mycobacterium tuberculosis and lipopolysaccharide were reduced among the 22 patients with poor outcome (P = .017). Low body mass index (P = .002) and elevated respiratory rate (P = .01) at tuberculosis diagnosis independently predicted poor outcome. Validation of a clinical score identifying high-risk individuals is warranted, together with further investigation of immunological derangements.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available